Auf dieser Seite
01UNH Preis
02Momentaufnahme
03Chart
04Aktiensplits
05Über uns
06Performance
07Bewertung & Kennzahlen
13Dividenden
14Erträge
15Vollständige Fundamentaldaten
16Erklärungen
17Institutionelle Eigentümer (13F)
18Aktivisten & 5%+-Eigentümer
19Unternehmensinsider
20ETF-Besitz
21Konsens
22Peers
23Nachrichten
25Handelssignale
26Meine Kennzahlen
UNH UnitedHealth Group Incorporated Common Stock (DE)
NYSE · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 10, 2026
$371,90
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$255,9752-Wochen-Tief
$461,6252-Wochen-Hoch
Marktkapitalisierung (MRQ)
$336.57B
P/E (TTM)
23.9
EPS (TTM)
$15.58
Umsatz (TTM)
$450.13B
Ihre Abzeichen
52W-Spanne
$256–$462
Analystenbewertung
BUY
Kursziel
$482
P/E
23.9
ROE
13.8%
Nettogewinnmarge
3.1%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
UNH Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$371.90
Marktkapitalisierung (MRQ)
$336.57B
P/E (TTM)
23.9
EPS (TTM)
$15.58
Umsatz (TTM)
$450.13B
Dividendenrendite
2.3%
ROE (TTM)
13.8%
Verschuldungsgrad (MRQ)
0.7
52W-Spanne
$256–$462
UNH Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 31. Mai 2005 | 2-for-1 | Vorwärts |
| 19. Juni 2003 | 2-for-1 | Vorwärts |
| 26. Dezember 2000 | 2-for-1 | Vorwärts |
| 11. März 1994 | 2-for-1 | Vorwärts |
| 16. September 1992 | 2-for-1 | Vorwärts |
Über UnitedHealth Group Incorporated Common Stock (DE) Unternehmensübersicht von Wikipedia
UnitedHealth ist ein US-amerikanischer börsennotierter Versicherungskonzern mit Firmensitz in Minnetonka, Minnesota. Das Unternehmen ist im Aktienindex S&P 500 gelistet und wurde im Oktober 2012 anstelle von Kraft Foods in den Dow Jones Industrial Average Index aufgenommen. Mit einem Umsatz von 324,2 Mrd. US-Dollar, bei einem Gewinn von 28,4 Mrd. US-Dollar, steht UnitedHealth laut den Forbes Global 2000 auf Platz 15 der weltgrößten Unternehmen (Stand: Jahr 2023). Laut den Fortune 500 gehört es zu den fünf umsatzstärksten Unternehmen der Vereinigten Staaten (Stand: Jahr 2022). Das Unternehmen kam Mitte 2022 auf eine Marktkapitalisierung von 504 Mrd. USD.
UnitedHealth bietet Versicherungen verschiedener Art an; insbesondere im Bereich der Krankenversicherung in den Vereinigten Staaten ist das Unternehmen sehr stark tätig. Im Unternehmen sind rund 400.000 Mitarbeiter beschäftigt.
Geschichte
UnitedHealth wurde 1977 unter dem Firmennamen UnitedHealthCare Corporation gegründet. 1995 erwarb UnitedHealth das US-amerikanische Unternehmen The MetraHealth Companies. 2006 war das Unternehmen in einen Finanzskandal verwickelt, der zum Rücktritt von William W. McGuire führte. Anfang 2022 wurde die Übernahme von Change Healthcare angekündigt, der größten Plattform für Gesundheitszahlungen in den USA. Aufgrund kartellrechtlicher Bedenken des US-Justizministerium konnte die Übernahme erst im Oktober 2022 endgültig vollzogen werden.
Im November 2023 wurde bekannt, dass der Konzern eine stark fehlerhafte Entscheidungssoftware genutzt hatte, um die Übernahme von Pflegekosten abzuwehren.
Am Morgen des 4. Dezember 2024 wurde der CEO der UnitedHealthcare Brian Thompson in Midtown Manhattan, New York City, vor dem Hotel New York Hilton Midtown, in dem UnitedHealth eine Investorentagung abhielt, erschossen.
Struktur
Die UnitedHealth Group hat zwei Tochtergesellschaften: Optum und UnitedHealthcare.
Optum
Optum wurde 2011 gegründet.
Es ist in drei Geschäftsbereiche unterteilt:
OptumHealth – bietet Primär- und Sekundärversorgung an.
OptumInsight – bietet Datenanalyse-, Technologie- und Betriebsdienstleistungen an.
OptumRX – bietet auch Apothekendienste an.
UnitedHealthcare
UnitedHealthcare ist ein Versicherungs- und Managed-Care-Unternehmen mit vier Hauptabteilungen:
UnitedHealthcare Employer and Individual – bietet Gesundheitsvorsorgepläne und Dienstleistungen für große nationale Arbeitgeber an.
UnitedHealthcare Medicare and Retirement – bietet Gesundheits- und Wellness-Dienstleistungen für Personen ab 65 Jahren an.
UnitedHealthcare Community and State – bedient staatliche Programme, die sich um wirtschaftlich Benachteiligte, medizinisch Unterversorgte und Menschen ohne arbeitgeberfinanzierten Gesundheitsschutz kümmern, im Austausch gegen eine monatliche Prämie pro Mitglied aus dem staatlichen Programm.
UnitedHealthcare Global – ist außerhalb der Vereinigten Staaten tätig
== Geschäftszahlen ==
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
SektorHealth Care
BrancheHealth Care
Mitarbeiter390.000
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$447.57B2021-12-31 → 2025-12-31
EPS$13.232021-12-31 → 2025-12-31
Freier Cashflow$16.07B2021-12-31 → 2025-12-31
Nettogewinnmarge3.1%2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | UNH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 23.9 | · | 36.3 | Unterbewertet | |
| P/S (TTM) | 0.7 | · | 0.7 | Teurer | |
| K/B (MRQ) | 3.2 | · | 3.9 | Fairer Wert | |
| EV / EBITDA | 20.1 | · | 16.1 | Überbewertet | |
| Kurs / FCF (TTM) | 14.3 | · | · | · | |
| Kurs / Cashflow (TTM) | 12.5 | · | 15.6 | Fairer Wert | |
| EV / Umsatz (TTM) | 0.8 | · | · | · | |
| EV / FCF (TTM) | 15.9 | · | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 4.0 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | UNH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 4.8% | · | 3.5% | Spitzenklasse | |
| EBITDA Margin (EBITDA-Marge) | 4.2% | · | 3.7% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | 3.9% | · | 2.8% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 3.1% | · | 2.9% | Spitzenklasse | |
| ROA (TTM) | 4.6% | · | 3.0% | Spitzenklasse | |
| ROE (TTM) | 13.8% | · | 10.1% | Spitzenklasse | |
| ROIC | 9.6% | · | 8.0% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | UNH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.7 | · | 0.7 | Im Einklang | |
| Liquiditätsgrad (MRQ) | 0.8 | · | 1.7 | Geringe Liquidität | |
| Quick Ratio (MRQ) | 0.5 | · | 1.3 | Geringe Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.7 | · | 0.7 | Im Einklang | |
| Interest Coverage (Zinsdeckungsgrad) | 4.7 | · | 4.4 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | UNH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 11.8% | · | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 11.3% | · | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 11.7% | · | · | · | |
| EPS YoY (EPS VjV) | -14.7% | · | · | · | |
| Net Income YoY (Nettogewinn YoY) | -16.3% | · | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | -14.5% | · | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | -3.8% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | -15.7% | · | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | -4.8% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | UNH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 1.5 | · | 2.4 | Schwach | |
| Inventory Turnover (Lagerumschlag) | 14.3 | · | · | · | |
| Receivables Turnover (Forderungsumschlag) | 19.7 | · | 16.3 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$1.1M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite2.3%
Ausschüttungsquote65.7%
Annualisierte Auszahlung≈$9.28
5J Div CAGR≈12.1%
Wachstumsphase≈16
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Sep 14, 2026 | $2,32 | USD | ≈2.4% |
| Jun 15, 2026 | $2,32 | USD | ≈2.2% |
| Mär 9, 2026 | $2,21 | USD | ≈3.1% |
| Dez 8, 2025 | $2,21 | USD | ≈2.7% |
| Sep 15, 2025 | $2,21 | USD | ≈2.5% |
| Jun 16, 2025 | $2,21 | USD | ≈2.8% |
| Mär 10, 2025 | $2,10 | USD | ≈1.7% |
| Dez 9, 2024 | $2,10 | USD | ≈1.5% |
| Sep 16, 2024 | $2,10 | USD | ≈1.4% |
| Jun 17, 2024 | $2,10 | USD | ≈1.6% |
| Mär 8, 2024 | $1,88 | USD | ≈1.6% |
| Dez 1, 2023 | $1,88 | USD | ≈1.3% |
| Sep 8, 2023 | $1,88 | USD | ≈1.5% |
| Jun 15, 2023 | $1,88 | USD | ≈1.5% |
| Mär 10, 2023 | $1,65 | USD | ≈1.4% |
| Dez 2, 2022 | $1,65 | USD | ≈1.2% |
| Sep 9, 2022 | $1,65 | USD | ≈1.2% |
| Jun 16, 2022 | $1,65 | USD | ≈1.3% |
| Mär 11, 2022 | $1,45 | USD | ≈1.2% |
| Dez 3, 2021 | $1,45 | USD | ≈1.2% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
4.7%
Nächster Bericht
Okt 13, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 16, 2026 | $6.38 | $4.95 | 28.8% |
| 31. März 2026 | $7.23 | $6.64 | 8.9% | |
| 31. Dezember 2025 | $2.11 | $2.12 | -0.57% | |
| 30. September 2025 | $2.92 | $2.82 | 3.5% | |
| 30. Juni 2025 | $4.08 | $4.53 | -9.9% | |
| 31. März 2025 | $7.20 | $7.36 | -2.2% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B | $257.14B | $242.16B | $226.25B | $201.16B | $184.84B | $157.11B | $130.47B | |
| Cost of Revenue | $50.66B | $46.69B | $38.77B | $33.70B | $31.03B | $30.75B | $28.12B | $27.00B | $24.11B | $24.42B | $16.21B | $3.83B | |
| SG&A Expense | $59.59B | $53.01B | $54.63B | $47.78B | $42.58B | $41.70B | $35.19B | $34.07B | $29.56B | $28.40B | $24.31B | $21.26B | |
| Operating Expenses | $428.60B | $367.99B | $339.26B | $295.73B | $263.63B | $234.74B | $222.47B | $208.90B | $185.95B | $171.91B | $146.09B | $120.20B | |
| Operating Income | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B | $19.68B | $17.34B | $15.21B | $12.93B | $11.02B | $10.27B | |
| Interest Expense | $4.00B | $3.91B | $3.25B | $2.09B | $1.66B | $1.66B | $1.70B | $1.40B | $1.19B | $1.07B | $790M | $618M | |
| Pretax Income | $14.70B | $20.07B | $29.11B | $26.34B | $22.31B | $20.74B | $17.98B | $15.94B | $14.02B | $11.86B | $10.23B | $9.66B | |
| Income Tax | $1.89B | $4.83B | $5.97B | $5.70B | $4.58B | $4.97B | $3.74B | $3.56B | $3.20B | $4.79B | $4.36B | $4.04B | |
| Net Income | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B | $10.56B | $7.02B | $5.81B | $5.62B | |
| EPS (Basic) | $13.28 | $15.64 | $24.12 | $21.47 | $18.33 | $16.23 | $14.55 | $12.45 | $10.95 | $7.37 | $6.10 | $5.78 | |
| EPS (Diluted) | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 | $16.03 | $14.33 | $12.19 | $10.72 | $7.25 | $6.01 | $5.70 | |
| Shares (Basic) | 908,000,000 | 921,000,000 | 928,000,000 | 937,000,000 | 943,000,000 | 949,000,000 | 951,000,000 | 963,000,000 | 964,000,000 | 952,000,000 | 953,000,000 | 972,000,000 | |
| Shares (Diluted) | 911,000,000 | 929,000,000 | 938,000,000 | 950,000,000 | 956,000,000 | 961,000,000 | 966,000,000 | 983,000,000 | 985,000,000 | 968,000,000 | 967,000,000 | 986,000,000 | |
| EBITDA | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B | $19.68B | $17.34B | $15.21B | $12.93B | $11.02B | $10.27B |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24.36B | $25.31B | $25.43B | $23.36B | $21.38B | $16.92B | $10.98B | $10.87B | $11.98B | $10.43B | $10.92B | $7.50B | |
| Short-term Investments | $3.76B | $3.80B | $4.20B | $4.55B | $2.53B | $2.86B | $3.26B | $3.46B | $3.51B | $2.85B | $1.99B | $1.74B | |
| Receivables | $23.02B | $22.36B | $21.28B | $17.68B | $14.22B | $12.87B | $11.82B | $11.39B | $9.57B | $8.15B | $6.52B | $4.25B | |
| Inventory | $3.30B | $3.80B | $2.80B | $3.50B | $2.90B | · | · | · | · | · | · | · | |
| Prepaid Expense | $9.75B | $8.21B | $6.08B | $6.62B | $5.32B | $4.46B | $3.85B | $3.09B | $2.66B | $1.85B | $2.41B | $1.05B | |
| Current Assets | $90.58B | $85.78B | $78.44B | $69.07B | $61.76B | $53.72B | $42.63B | $38.69B | $37.08B | $33.88B | $31.64B | $23.56B | |
| PP&E (Net) | $10.76B | $10.55B | $11.45B | $10.13B | $8.97B | $8.63B | $8.70B | $8.46B | $7.01B | $5.90B | $4.86B | $4.42B | |
| Accum. Depreciation | $7.55B | $6.97B | $7.04B | $6.93B | $5.99B | $5.23B | $5.00B | $4.14B | $3.69B | $3.75B | $3.17B | $2.95B | |
| Goodwill | $110.50B | $106.73B | $103.73B | $93.35B | $75.80B | $71.34B | $65.66B | $58.91B | $54.56B | $47.58B | $44.45B | $32.94B | |
| Intangibles | $20.47B | $23.27B | $15.19B | $14.40B | $10.04B | $10.86B | $10.35B | $9.32B | $8.49B | $8.54B | $8.39B | $3.67B | |
| Other Non-current Assets | $23.01B | $19.59B | $17.30B | $15.03B | $12.53B | $11.51B | $9.33B | $4.33B | $3.58B | $3.04B | $3.12B | $2.97B | |
| Total Assets | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B | $152.22B | $139.06B | $122.81B | $111.25B | $86.30B | |
| Accounts Payable | $38.03B | $34.34B | $31.96B | $27.71B | $24.64B | $22.50B | $19.00B | $16.70B | $15.18B | $13.36B | $11.99B | $9.25B | |
| Current Liabilities | $114.90B | $103.77B | $99.05B | $89.24B | $78.29B | $72.42B | $61.78B | $53.21B | $50.46B | $49.25B | $42.90B | $30.62B | |
| Deferred Tax | $2.42B | $3.62B | $3.02B | $2.77B | $3.27B | $3.37B | $2.99B | $2.47B | $2.18B | $2.76B | $3.59B | $2.06B | |
| Other Non-current Liabilities | $18.25B | $15.94B | $14.46B | $12.84B | $11.79B | $12.31B | $10.14B | $5.73B | $5.56B | $4.83B | $1.48B | $1.36B | |
| Total Liabilities | $207.88B | $195.69B | $174.80B | $159.36B | $135.73B | $126.75B | $111.73B | $95.99B | $87.04B | $82.62B | $75.79B | $52.54B | |
| Long-term Debt | · | · | · | · | $46.00B | $43.47B | $40.68B | $36.55B | $31.69B | $32.97B | $31.96B | $17.41B | |
| Total Debt | $72.32B | $72.36B | $58.26B | $54.51B | $46.00B | $43.47B | $40.68B | $36.55B | $31.69B | $32.97B | $32.09B | $17.41B | |
| Common Stock | $9M | $9M | $9M | $9M | $10M | $10M | $9M | $10M | $10M | $10M | $10M | $10M | |
| Paid-in Capital | $559M | $0 | $0 | · | $0 | $0 | $7M | $0 | $1.70B | $0 | $29M | $0 | |
| Retained Earnings | $95.60B | $96.04B | $95.77B | $86.16B | $77.13B | $69.30B | $61.18B | $55.85B | $48.73B | $40.95B | $37.12B | $33.84B | |
| AOCI | $-2.06B | $-3.39B | $-7.03B | $-8.39B | $-5.38B | $-3.81B | $-3.58B | $-4.16B | $-2.67B | $-2.68B | $-3.33B | $-1.39B | |
| Stockholders' Equity | $100.09B | $98.27B | $94.42B | $81.45B | $75.05B | $68.33B | $60.44B | $54.32B | $49.83B | $38.18B | $33.73B | $32.45B | |
| Liabilities + Equity | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B | $152.22B | $139.06B | $122.81B | $111.25B | $86.38B | |
| Shares Outstanding | 906,000,000 | 915,000,000 | 924,000,000 | 934,000,000 | 941,000,000 | 946,000,000 | 948,000,000 | 960,000,000 | 969,000,000 | 952,000,000 | 953,000,000 | 954,000,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4.36B | $4.10B | $3.97B | $3.40B | $3.10B | $2.89B | $2.72B | $2.43B | $2.25B | $2.06B | $1.69B | $1.48B | |
| Stock-based Comp | $971M | $1.02B | $1.06B | $925M | $800M | $679M | $697M | $638M | $597M | $485M | $406M | $364M | |
| Deferred Tax | $-1.75B | $-296M | $-245M | $-673M | $130M | $-8M | $230M | $42M | $-965M | $81M | $-73M | $-117M | |
| Amort. of Intangibles | $1.70B | $1.70B | $1.60B | $1.30B | $1.20B | $1.10B | $1.00B | $898M | $896M | $882M | $650M | $524M | |
| Operating Cash Flow | $19.70B | $24.20B | $29.07B | $26.21B | $22.34B | $22.17B | $18.46B | $15.71B | $13.60B | $9.79B | $9.74B | $8.05B | |
| CapEx | $3.62B | $3.50B | $3.39B | $2.80B | $2.45B | $2.05B | $2.07B | $2.06B | $2.02B | $1.71B | $1.56B | $1.52B | |
| Investing Cash Flow | $-8.69B | $-20.53B | $-15.57B | $-28.48B | $-10.37B | $-12.53B | $-12.70B | $-12.38B | $-8.60B | $-9.36B | $-18.39B | $-2.53B | |
| Debt Issued | $2.97B | $17.81B | $6.39B | $14.82B | $6.93B | $4.86B | $5.44B | $6.93B | $5.29B | $3.97B | $11.98B | $2.00B | |
| Net Debt Issued | $-81M | $14.81B | $4.27B | $11.80B | $3.78B | $1.71B | $3.69B | $4.33B | $893M | $1.37B | $10.94B | $1.19B | |
| Stock Issued | $827M | $1.85B | $1.35B | $1.25B | $1.35B | $1.44B | $1.04B | $838M | $688M | $429M | $402M | $462M | |
| Stock Repurchased | $5.54B | $9.00B | $8.00B | $7.00B | $5.00B | $4.25B | $5.50B | $4.50B | $1.50B | $1.28B | $1.20B | $4.01B | |
| Net Stock Activity | $-4.72B | $-7.15B | $-6.65B | $-5.75B | $-3.65B | $-2.81B | $-4.46B | $-3.66B | $-812M | $-851M | $-798M | $-3.55B | |
| Dividends Paid | $7.92B | $7.53B | $6.76B | $5.99B | $5.28B | $4.58B | $3.93B | $3.32B | $2.77B | $2.26B | $1.79B | $1.36B | |
| Financing Cash Flow | $-11.64B | $-3.51B | $-11.53B | $4.23B | $-7.46B | $-3.59B | $-5.62B | $-4.37B | $-3.44B | $-1.01B | $12.24B | $-5.29B | |
| Net Change in Cash | $-947M | $-115M | $2.06B | $1.99B | $4.45B | $5.94B | $119M | $-1.11B | $1.55B | $-493M | $3.43B | $219M | |
| Taxes Paid | $3.71B | $4.62B | $6.08B | $5.22B | $3.97B | $4.93B | $3.54B | $3.26B | $4.00B | $4.73B | $4.40B | $4.02B | |
| Free Cash Flow | $16.07B | $20.70B | $25.68B | $23.40B | $19.89B | $20.12B | $16.39B | $13.65B | $11.57B | $8.09B | $8.18B | $6.53B | |
| Levered FCF | $12.59B | $17.74B | $23.10B | $21.76B | $18.57B | $18.86B | $15.04B | $12.56B | $10.66B | $7.45B | $7.73B | $6.17B |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 4.2% | 8.1% | 8.7% | 8.8% | 8.3% | 8.7% | 8.1% | 7.7% | 7.6% | 7.0% | 7.0% | 7.9% | |
| Net Margin | 2.7% | 3.6% | 6.0% | 6.2% | 6.0% | 6.0% | 5.7% | 5.3% | 5.2% | 3.8% | 3.7% | 4.3% | |
| Pretax Margin | 3.3% | 5.0% | 7.8% | 8.1% | 7.8% | 8.1% | 7.4% | 7.0% | 7.0% | 6.4% | 6.5% | 7.4% | |
| EBITDA Margin | 4.2% | 8.1% | 8.7% | 8.8% | 8.3% | 8.7% | 8.1% | 7.7% | 7.6% | 7.0% | 7.0% | 7.9% | |
| ROA | 4.0% | 4.8% | 8.6% | 8.8% | 8.4% | 8.3% | 8.5% | 8.2% | 8.1% | 6.0% | 5.9% | 6.7% | |
| ROE | 12.0% | 14.5% | 24.3% | 25.2% | 23.3% | 22.6% | 23.4% | 22.4% | 21.7% | 18.5% | 17.4% | 17.3% | |
| ROIC | 9.6% | 14.4% | 16.9% | 16.4% | 15.7% | 15.2% | 15.4% | 14.8% | 14.4% | 10.8% | 9.6% | 12.0% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | |
| Quick Ratio | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.4 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.6 | 0.9 | 1.0 | 0.5 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.8 | 0.5 | |
| Interest Coverage | 4.7 | 8.3 | 10.0 | 13.6 | 14.4 | 13.5 | 11.6 | 12.4 | 12.8 | 12.1 | 14.0 | 16.6 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.5 | 1.3 | 1.4 | 1.4 | 1.4 | 1.4 | 1.5 | 1.6 | 1.5 | 1.6 | 1.6 | 1.6 | |
| Inventory Turnover | 14.3 | 14.1 | 12.3 | 10.5 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 19.7 | 18.3 | 19.1 | 20.3 | 21.2 | 20.8 | 20.9 | 21.6 | 22.7 | 25.2 | 29.2 | 35.7 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $110.47 | $107.40 | $102.19 | $87.21 | $79.75 | $72.23 | $63.75 | $56.58 | $51.43 | $40.10 | $35.39 | $34.02 | |
| Revenue / Share | $491.29 | $430.87 | $396.19 | $341.22 | $300.83 | $267.58 | $250.68 | $230.16 | $204.22 | $190.95 | $162.47 | $132.33 | |
| Cash Flow / Share | $21.62 | $26.05 | $30.99 | $27.59 | $23.37 | $23.07 | $19.11 | $15.98 | $13.80 | $10.12 | $10.07 | $8.17 | |
| Cash / Share | $26.89 | $27.66 | $27.52 | $25.02 | $22.72 | $17.89 | $11.59 | $11.32 | $12.36 | $10.96 | $11.46 | $7.86 | |
| Dividend / Share | · | · | · | · | · | · | · | · | $2.88 | $2.38 | $1.88 | $1.41 | |
| Dividend Paid / Share | $8.73 | $8.18 | $7.29 | $6.40 | $5.60 | $4.83 | $4.14 | $3.45 | $2.88 | $2.38 | $1.88 | $1.41 | |
| EPS (TTM) | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 | $16.03 | $14.33 | $12.19 | $10.72 | $7.25 | $6.01 | $5.70 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 7.7% | 14.6% | 12.7% | 11.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.3% | 11.7% | 13.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.7% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -14.7% | -35.0% | 12.7% | 17.2% | 12.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -14.5% | -5.0% | 14.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -16.3% | -35.6% | 11.2% | 16.4% | 12.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -15.7% | -5.9% | 13.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -4.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 11.6% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B | $257.14B | $242.16B | $226.25B | $201.16B | $184.84B | $157.11B | $130.47B | |
| Net Income TTM | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B | $10.56B | $7.02B | $5.81B | $5.62B | |
| Market Cap | $299.08B | $462.86B | $486.46B | $495.19B | $472.51B | $331.74B | $278.69B | $239.16B | $213.63B | $152.36B | $112.11B | $96.44B | |
| Enterprise Value | $343.28B | $506.11B | $515.09B | $521.79B | $494.61B | $355.43B | $305.13B | $261.39B | $229.83B | $172.05B | $131.29B | $104.61B | |
| P/E | 25.0 | 32.6 | 22.1 | 25.0 | 27.8 | 21.9 | 20.5 | 20.4 | 20.6 | 22.1 | 19.6 | 17.7 | |
| P/S | 0.7 | 1.2 | 1.3 | 1.5 | 1.6 | 1.3 | 1.2 | 1.1 | 1.1 | 0.8 | 0.7 | 0.7 | |
| P/B | 3.0 | 4.7 | 5.2 | 6.1 | 6.3 | 4.9 | 4.6 | 4.4 | 4.3 | 4.0 | 3.3 | 3.0 | |
| P / Cash Flow | 15.2 | 19.1 | 16.7 | 18.9 | 21.1 | 15.0 | 15.1 | 15.2 | 15.7 | 15.6 | 11.5 | 12.0 | |
| P / FCF | 18.6 | 22.4 | 18.9 | 21.2 | 23.8 | 16.5 | 17.0 | 17.5 | 18.5 | 18.8 | 13.7 | 14.8 | |
| EV / EBITDA | 18.1 | 15.7 | 15.9 | 18.4 | 20.6 | 15.9 | 15.5 | 15.1 | 15.1 | 13.3 | 11.9 | 10.2 | |
| EV / FCF | 21.4 | 24.4 | 20.1 | 22.3 | 24.9 | 17.7 | 18.6 | 19.1 | 19.9 | 21.3 | 16.0 | 16.0 | |
| EV / Revenue | 0.8 | 1.3 | 1.4 | 1.6 | 1.7 | 1.4 | 1.3 | 1.2 | 1.1 | 0.9 | 0.8 | 0.8 | |
| Dividend Yield | 2.6% | 1.6% | 1.4% | 1.2% | 1.1% | 1.4% | 1.4% | 1.4% | 1.3% | 1.5% | 1.6% | 1.4% | |
| Earnings Yield | 4.0% | 3.1% | 4.5% | 4.0% | 3.6% | 4.6% | 4.9% | 4.9% | 4.9% | 4.5% | 5.1% | 5.6% | |
| Payout Ratio | 65.7% | 52.3% | 30.2% | 29.8% | 30.6% | 29.8% | 28.4% | 27.7% | 26.3% | 32.2% | 30.7% | 24.2% | |
| Annual Payout | $7.92B | $7.53B | $6.76B | $5.99B | $5.28B | $4.58B | $3.93B | $3.32B | $2.77B | $2.26B | $1.79B | $1.36B |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $112.03B | $111.72B | $113.22B | $113.16B | $111.62B | $109.58B | $100.81B | $100.82B | $98.86B | $99.80B | $94.43B | $92.36B | $92.90B | $91.93B | $82.79B | $80.89B | |
| Cost of Revenue | $13.38B | $12.82B | $12.68B | $12.57B | $13.02B | $12.39B | $12.46B | $11.83B | $11.34B | $11.06B | $10.19B | $9.42B | $9.75B | $9.40B | $8.31B | $8.31B | |
| SG&A Expense | $14.27B | $15.39B | $17.00B | $15.22B | $13.78B | $13.59B | $12.49B | $13.28B | $13.16B | $14.08B | $13.34B | $13.86B | $13.81B | $13.62B | $13.01B | $11.66B | |
| Operating Expenses | $104.04B | $102.73B | $112.83B | $108.85B | $106.47B | $100.46B | $93.03B | $92.11B | $90.98B | $91.86B | $86.74B | $83.83B | $84.85B | $83.84B | $75.90B | $73.43B | |
| Operating Income | $7.99B | $8.99B | $380M | $4.32B | $5.15B | $9.12B | $7.77B | $8.71B | $7.88B | $7.93B | $7.69B | $8.53B | $8.06B | $8.09B | $6.89B | $7.46B | |
| Interest Expense | $962M | $955M | $974M | $1.00B | $1.03B | $998M | $1.00B | $1.07B | $985M | $844M | $830M | $834M | $828M | $754M | $676M | $516M | |
| Pretax Income | $6.97B | $7.96B | $-720M | $3.23B | $4.08B | $8.11B | $6.79B | $7.61B | $5.67B | $1M | $6.86B | $7.69B | $7.23B | $7.33B | $6.21B | $6.95B | |
| Income Tax | $1.30B | $1.48B | $-938M | $686M | $510M | $1.63B | $1.01B | $1.36B | $1.24B | $1.22B | $1.18B | $1.65B | $1.57B | $1.56B | $1.31B | $1.56B | |
| Net Income | $5.48B | $6.28B | $10M | $2.35B | $3.41B | $6.29B | $5.54B | $6.05B | $4.22B | $-1.41B | $5.46B | $5.84B | $5.47B | $5.61B | $4.76B | $5.26B | |
| EPS (Basic) | $6.06 | $6.92 | $0.03 | $2.59 | $3.76 | $6.90 | $6.03 | $6.56 | $4.58 | $-1.53 | $5.91 | $6.31 | $5.89 | $6.01 | $5.09 | $5.63 | |
| EPS (Diluted) | $6.04 | $6.90 | $0.05 | $2.59 | $3.74 | $6.85 | $5.99 | $6.51 | $4.54 | $-1.53 | $5.85 | $6.24 | $5.82 | $5.95 | $5.02 | $5.55 | |
| Shares (Basic) | 902,000,000 | 908,000,000 | · | 906,000,000 | 907,000,000 | 912,000,000 | · | 923,000,000 | 921,000,000 | 922,000,000 | · | 926,000,000 | 930,000,000 | 933,000,000 | · | 935,000,000 | |
| Shares (Diluted) | 906,000,000 | 910,000,000 | · | 908,000,000 | 910,000,000 | 918,000,000 | · | 930,000,000 | 928,000,000 | 922,000,000 | · | 936,000,000 | 940,000,000 | 943,000,000 | · | 948,000,000 | |
| EBITDA | $7.99B | $8.99B | · | $4.32B | $5.15B | $9.12B | · | $8.71B | $7.88B | $7.93B | · | $8.53B | $8.06B | $8.09B | · | $7.46B |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $28.59B | $28.00B | $24.36B | $27.21B | $28.60B | $30.72B | $25.31B | $32.40B | $26.29B | $28.41B | · | $38.91B | $41.81B | $41.91B | · | $38.84B | |
| Short-term Investments | $2.88B | $3.23B | $3.76B | $3.40B | $3.42B | $3.57B | $3.80B | $4.73B | $5.04B | $4.30B | · | $5.18B | $4.47B | $4.58B | · | $3.68B | |
| Receivables | $21.57B | $26.59B | $23.02B | $22.67B | $24.14B | $26.94B | $22.36B | $20.02B | $23.11B | $27.20B | · | $20.67B | $17.95B | $22.41B | · | $17.05B | |
| Inventory | · | · | $3.30B | · | · | · | $3.80B | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $9.10B | $8.72B | $9.75B | $9.02B | $8.96B | $9.04B | $8.21B | $7.64B | $7.42B | $6.13B | · | $5.77B | $5.88B | $6.45B | · | $5.66B | |
| Current Assets | $86.86B | $91.13B | $90.58B | $95.07B | $93.70B | $96.28B | $85.78B | $92.26B | $92.04B | $88.94B | · | $91.91B | $89.87B | $93.89B | · | $82.94B | |
| PP&E (Net) | $10.76B | $10.67B | $10.76B | $11.10B | $10.92B | $10.73B | $10.55B | $10.14B | $9.80B | $10.43B | · | $11.07B | $10.93B | $10.64B | · | $9.47B | |
| Accum. Depreciation | · | · | $7.55B | · | · | · | $6.97B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $110.64B | $110.51B | $110.50B | $110.34B | $107.68B | $107.57B | $106.73B | $105.98B | $105.44B | $105.66B | $103.73B | $101.70B | $101.67B | $100.41B | $93.35B | $83.90B | |
| Intangibles | $19.75B | $20.09B | $20.47B | $22.79B | $22.51B | $22.95B | $23.27B | $23.59B | $14.73B | $15.54B | · | $15.20B | $15.64B | $16.16B | · | $10.79B | |
| Other Non-current Assets | $24.00B | $23.46B | $23.01B | $22.98B | $21.30B | $20.39B | $19.59B | $18.65B | $17.94B | $17.70B | · | $16.71B | $16.07B | $15.69B | · | $14.41B | |
| Total Assets | $309.73B | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | $298.28B | $299.31B | $286.06B | $284.21B | $273.72B | $282.06B | $280.16B | $283.68B | $245.71B | $243.06B | |
| Accounts Payable | $39.74B | $38.63B | $38.03B | $36.03B | $34.33B | $33.57B | $34.34B | $33.08B | $30.89B | $30.74B | · | $31.16B | $29.52B | $29.86B | · | $27.23B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | $7.30B | · | $2.60B | $4.40B | $8.20B | · | · | |
| Current Liabilities | $111.82B | $114.12B | $114.90B | $115.53B | $110.78B | $113.47B | $103.77B | $101.56B | $104.67B | $104.43B | · | $114.18B | $112.98B | $116.48B | · | $100.94B | |
| Deferred Tax | $2.72B | $2.86B | $2.42B | $3.16B | $3.80B | $3.90B | $3.62B | $4.01B | $3.63B | $4.17B | · | $2.21B | $2.50B | $2.83B | · | $1.66B | |
| Other Non-current Liabilities | $19.73B | $18.90B | $18.25B | $18.37B | $15.71B | $15.96B | $15.94B | $15.17B | $14.79B | $14.84B | · | $13.62B | $13.26B | $13.08B | · | $12.11B | |
| Total Liabilities | $203.78B | $207.32B | $207.88B | $209.46B | $203.79B | $204.62B | $195.69B | $194.85B | $186.82B | $187.29B | · | $188.08B | $188.01B | $193.06B | · | $160.14B | |
| Total Debt | $69.50B | $71.44B | · | $72.40B | $73.50B | $71.28B | · | $74.10B | $63.73B | $71.15B | · | $60.68B | $63.67B | $68.86B | · | $45.44B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $10M | |
| Paid-in Capital | $0 | $556M | $559M | $394M | · | · | $0 | $461M | $373M | · | · | · | · | · | · | · | |
| Retained Earnings | $100.96B | $99.88B | $95.60B | $97.59B | $97.25B | $97.93B | $96.04B | $96.52B | $92.40B | $90.12B | · | $93.17B | $89.99B | $88.85B | · | $83.72B | |
| AOCI | $-2.52B | $-2.56B | $-2.06B | $-2.21B | $-2.54B | $-2.90B | $-3.39B | $-2.45B | $-3.42B | $-3.44B | · | $-8.69B | $-7.65B | $-7.55B | · | $-9.09B | |
| Stockholders' Equity | $104.51B | $103.89B | $100.09B | $101.57B | $100.47B | $100.81B | $98.27B | $99.88B | $94.68B | $92.37B | $94.42B | $89.56B | $87.37B | $85.82B | $81.45B | $78.06B | |
| Liabilities + Equity | $309.73B | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | $298.28B | $299.31B | $286.06B | $284.21B | · | $282.06B | $280.16B | $283.68B | · | $243.06B | |
| Shares Outstanding | 905,000,000 | 908,000,000 | 906,000,000 | 906,000,000 | 905,000,000 | 910,000,000 | 915,000,000 | 923,000,000 | 921,000,000 | 920,000,000 | 924,000,000 | 925,000,000 | 927,000,000 | 932,000,000 | 934,000,000 | 935,000,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.04B | $1.03B | $1.12B | $1.10B | $1.08B | $1.06B | $1.04B | $1.04B | $1.02B | $997M | $974M | $1.01B | $1.02B | $970M | $982M | $828M | |
| Stock-based Comp | $276M | $348M | $176M | $223M | $197M | $375M | $187M | $237M | $222M | $372M | $208M | $247M | $242M | $362M | $250M | $171M | |
| Deferred Tax | $-129M | $540M | $-733M | $-932M | $-151M | $64M | $-62M | $124M | $-331M | $-27M | $249M | $-12M | $-150M | $-332M | $-83M | $-575M | |
| Operating Cash Flow | $11.05B | $8.91B | $1.11B | $5.95B | $7.19B | $5.46B | $2.37B | $13.95B | $6.75B | $1.14B | $-5.19B | $6.90B | $11.03B | $16.33B | $-4.53B | $18.55B | |
| CapEx | $799M | $763M | $948M | $890M | $886M | $898M | $912M | $991M | $853M | $743M | $959M | $838M | $829M | $760M | $866M | $724M | |
| Investing Cash Flow | $-1.80B | $-2.45B | $-2.61B | $-4.56B | $-1.44B | $-74M | $-1.12B | $-5.65B | $-7.42B | $-6.34B | $-1.19B | $-2.64B | $-728M | $-11.02B | $-15.37B | $-847M | |
| Debt Issued | · | · | $0 | $0 | $2.97B | $0 | $0 | $11.89B | $0 | $5.92B | $0 | $0 | $-7M | $6.40B | $8.90B | $0 | |
| Net Debt Issued | · | $-1.50B | · | · | · | $0 | · | · | · | $5.17B | · | · | · | $5.03B | · | · | |
| Stock Issued | $128M | $231M | $24M | $222M | $221M | $360M | $235M | $867M | $258M | $486M | $314M | $411M | $284M | $344M | $169M | $328M | |
| Stock Repurchased | $1.65B | $0 | $0 | $0 | $2.54B | $3.00B | $4.97B | $956M | $0 | $3.07B | $1.50B | $1.50B | $3.00B | $2.00B | $1.00B | $1.00B | |
| Net Stock Activity | · | $231M | · | · | · | $-2.64B | · | · | · | $-2.59B | · | · | · | $-1.66B | · | · | |
| Dividends Paid | $2.09B | $2.00B | $2.00B | $2.00B | $2.00B | $1.91B | $1.93B | $1.94B | $1.94B | $1.73B | $1.74B | $1.74B | $1.75B | $1.54B | $1.54B | $1.54B | |
| Financing Cash Flow | $-8.62B | $-2.99B | $-1.03B | $-2.77B | $-7.95B | $99M | $-8.34B | $-2.21B | $-1.20B | $8.23B | $-7.16B | $-7.10B | $-10.46B | $13.19B | $4.39B | $-3.42B | |
| Net Change in Cash | $584M | $3.64B | $-2.85B | $-1.39B | $-2.12B | $5.41B | $-7.09B | $6.11B | $-2.13B | $2.99B | $-13.49B | $-2.90B | $-100M | $18.55B | $-15.48B | $14.23B | |
| Free Cash Flow | · | $8.15B | · | · | · | $4.56B | · | · | · | $401M | · | · | · | $15.57B | · | · | |
| Levered FCF | · | $7.37B | · | · | · | $3.76B | · | · | · | $1.03T | · | · | · | $14.97B | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 7.1% | 8.1% | · | 3.8% | 4.6% | 8.3% | · | 8.6% | 8.0% | 8.0% | · | 9.2% | 8.7% | 8.8% | · | 9.2% | |
| Net Margin | 4.9% | 5.6% | · | 2.1% | 3.0% | 5.7% | · | 6.0% | 4.3% | -1.4% | · | 6.3% | 5.9% | 6.1% | · | 6.5% | |
| Pretax Margin | 6.2% | 7.1% | · | 2.9% | 3.7% | 7.4% | · | 7.5% | 5.7% | 0.00% | · | 8.3% | 7.8% | 8.0% | · | 8.6% | |
| EBITDA Margin | 7.1% | 8.1% | · | 3.8% | 4.6% | 8.3% | · | 8.6% | 8.0% | 8.0% | · | 9.2% | 8.7% | 8.8% | · | 9.2% | |
| ROA | 1.8% | 2.0% | · | 0.76% | 1.1% | 2.1% | · | 2.1% | 1.5% | -0.50% | · | 2.2% | 2.1% | 2.2% | · | 2.3% | |
| ROE | 5.3% | 6.1% | · | 2.3% | 3.5% | 6.5% | · | 6.4% | 4.6% | -1.6% | · | 7.0% | 6.7% | 6.9% | · | 7.0% | |
| ROIC | 3.7% | 4.2% | · | 1.9% | 2.6% | 4.2% | · | 4.1% | 3.9% | -5922.1% | · | 4.5% | 4.2% | 4.1% | · | 4.7% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| Quick Ratio | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | |
| LT Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | |
| Interest Coverage | 8.3 | 9.4 | · | 4.3 | 5.0 | 9.1 | · | 8.1 | 8.0 | 9.4 | · | 10.2 | 9.7 | 10.7 | · | 14.5 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 4.9 | 4.2 | · | 5.3 | 4.7 | 4.0 | · | 5.0 | 4.8 | 4.0 | · | 4.9 | 5.1 | 4.5 | · | 5.2 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $115.48 | $114.42 | · | $112.11 | $111.02 | $110.78 | · | $108.21 | $102.80 | $100.40 | · | $96.83 | $94.25 | $92.08 | · | $83.49 | |
| Revenue / Share | $123.66 | $122.77 | · | $124.63 | $122.65 | $119.36 | · | $108.41 | $106.52 | $108.24 | · | $98.68 | $98.83 | $97.49 | · | $85.33 | |
| Cash Flow / Share | · | $9.79 | · | · | · | $5.94 | · | · | · | $1.24 | · | · | · | $17.31 | · | · | |
| Cash / Share | $31.59 | $30.84 | · | $30.03 | $31.60 | $33.75 | · | $35.10 | $28.54 | $30.88 | · | $42.07 | $45.11 | $44.97 | · | $41.55 | |
| Dividend Paid / Share | $2.32 | $2.21 | $2.21 | $2.21 | $2.21 | $2.10 | $2.10 | $2.10 | $2.10 | $1.88 | $1.88 | $1.88 | $1.88 | $1.65 | $1.65 | $1.65 | |
| EPS (TTM) | $15.58 | $13.28 | · | $19.17 | $23.09 | $23.89 | · | $15.37 | $15.10 | $16.38 | · | $23.03 | $22.34 | $21.86 | · | $20.42 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $450.13B | $449.71B | · | $435.16B | $422.82B | $410.06B | · | $393.90B | $385.44B | $379.49B | · | $359.98B | $348.51B | $335.94B | · | $315.12B | |
| Net Income TTM | $14.12B | $12.04B | · | $17.59B | $21.30B | $22.11B | · | $14.32B | $14.10B | $15.36B | · | $21.69B | $21.11B | $20.70B | · | $19.43B | |
| Market Cap | $376.15B | $245.70B | · | $312.84B | $282.33B | $476.61B | · | $539.66B | $469.03B | $455.12B | · | $466.38B | $445.55B | $440.45B | · | $472.21B | |
| Enterprise Value | $414.18B | $285.91B | · | $354.63B | $323.81B | $513.61B | · | $576.63B | $501.43B | $493.56B | · | $482.96B | $462.94B | $462.81B | · | $475.12B | |
| P/E | 26.7 | 20.4 | · | 18.0 | 13.5 | 21.9 | · | 38.0 | 33.7 | 30.2 | · | 21.9 | 21.5 | 21.6 | · | 24.7 | |
| P/S | 0.8 | 0.5 | · | 0.7 | 0.7 | 1.2 | · | 1.4 | 1.2 | 1.2 | · | 1.3 | 1.3 | 1.3 | · | 1.5 | |
| P/B | 3.6 | 2.4 | · | 3.1 | 2.8 | 4.7 | · | 5.4 | 5.0 | 4.9 | · | 5.2 | 5.1 | 5.1 | · | 6.0 | |
| P / Cash Flow | · | 27.6 | · | · | · | 87.4 | · | · | · | 397.8 | · | · | · | 27.0 | · | · | |
| EV / Revenue | 0.9 | 0.6 | · | 0.8 | 0.8 | 1.3 | · | 1.5 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.4 | · | 1.5 | |
| Dividend Yield | 2.1% | 3.3% | · | 2.5% | 2.8% | 1.6% | · | 1.4% | 1.5% | 1.5% | · | 1.4% | 1.4% | 1.4% | · | 1.2% | |
| Earnings Yield | 3.8% | 4.9% | · | 5.5% | 7.4% | 4.6% | · | 2.6% | 3.0% | 3.3% | · | 4.6% | 4.7% | 4.6% | · | 4.0% | |
| Payout Ratio | · | 31.9% | · | · | · | 30.4% | · | · | · | -122.7% | · | · | · | 27.4% | · | · | |
| Annual Payout | $8.10B | $8.01B | · | $7.85B | $7.78B | $7.72B | · | $7.34B | $7.14B | $6.95B | · | $6.56B | $6.37B | $6.17B | · | $5.82B |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| Umsatz | $447.57B | · | · | $400.28B | · |
| Betriebsgewinnmarge % | 4.2% | · | · | 8.1% | · |
| Nettoergebnis | $12.06B | · | · | $14.40B | · |
| Verwässerte EPS | $13.23 | · | · | $15.51 | · |
| Kennzahl | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.7 | · | · | 0.7 | · |
| Liquiditätsgrad | 0.8 | · | · | 0.8 | · |
| Quick Ratio | 0.4 | · | · | 0.5 | · |
| Kennzahl | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| Freier Cashflow | $16.07B | · | · | $20.70B | · |
Institutionelle Eigentümer (13F) 3.707 Einreicher · $370.2B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
3.707
Gehaltener Wert
$370.2B
Neue Positionen
511
Geschlossene Positionen
124
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 511 (+255 vs. Vorquartal) | 124 (-255 vs. Vorquartal) | 1.310 (+88 vs. Vorquartal) | 1.307 (-101 vs. Vorquartal) | +16.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $31.946.594.368 | 76.863.061 | 8,63% | Aktien |
| VANGUARD GROUP INC | $30.238.161.829 | 91.600.260 | 8,17% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $24.651.649.136 | 59.311.525 | 6,66% | Aktien |
| STATE STREET CORP | $18.966.554.763 | 45.633.267 | 5,12% | Aktien |
| Capital World Investors | $12.422.776.956 | 29.887.932 | 3,36% | Aktien |
| FMR LLC | $11.634.728.621 | 27.992.995 | 3,14% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10.175.966.547 | 24.483.234 | 2,75% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $9.008.139.395 | 21.751.937 | 2,43% | Aktien |
| JPMORGAN CHASE & CO | $8.499.696.736 | 20.246.047 | 2,30% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $8.242.777.944 | 19.830.588 | 2,23% | Aktien |
| MORGAN STANLEY | $6.149.436.946 | 14.795.456 | 1,66% | Aktien |
| NORGES BANK | $5.293.868.088 | 12.736.973 | 1,43% | Aktien |
| Bank of New York Mellon Corp | $4.449.316.683 | 10.704.994 | 1,20% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $4.436.922.985 | 10.675.175 | 1,20% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.403.973.917 | 10.595.900 | 1,19% | Kaufoption |
| Capital Research Global Investors | $4.378.631.657 | 10.534.177 | 1,18% | Aktien |
| BANK OF AMERICA CORP /DE/ | $4.046.521.317 | 9.735.874 | 1,09% | Aktien |
| Fisher Asset Management, LLC | $3.774.863.715 | 9.082.269 | 1,02% | Aktien |
| Dodge & Cox | $3.770.702.593 | 9.072.258 | 1,02% | Aktien |
| NORTHERN TRUST CORP | $3.641.357.289 | 8.761.055 | 0,98% | Aktien |
| FRANKLIN RESOURCES INC | $3.592.618.078 | 8.643.789 | 0,97% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.484.641.920 | 8.384.000 | 0,94% | Verkaufsoption |
| JANE STREET GROUP, LLC | $3.473.960.229 | 8.358.300 | 0,94% | Kaufoption |
| Capital International Investors | $3.237.872.783 | 7.789.028 | 0,87% | Aktien |
| GOLDMAN SACHS GROUP INC | $2.898.658.338 | 6.974.132 | 0,78% | Aktien |
| Invesco Ltd. | $2.850.799.411 | 6.858.984 | 0,77% | Aktien |
| CITADEL ADVISORS LLC | $2.632.849.798 | 6.334.600 | 0,71% | Kaufoption |
| Sanders Capital, LLC | $2.451.649.249 | 5.898.634 | 0,66% | Aktien |
| Legal & General Group Plc | $2.444.927.690 | 5.882.462 | 0,66% | Aktien |
| EAGLE CAPITAL MANAGEMENT LLC | $2.399.442.912 | 5.773.026 | 0,65% | Aktien |
| CITADEL ADVISORS LLC | $2.340.745.034 | 5.631.800 | 0,63% | Verkaufsoption |
| ROYAL BANK OF CANADA | $2.153.793.000 | 5.181.995 | 0,58% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.119.167.278 | 5.098.687 | 0,57% | Aktien |
| Amundi | $2.100.894.352 | 5.054.732 | 0,57% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $2.075.268.358 | 7.669.420 | 0,56% | Aktien |
| JANE STREET GROUP, LLC | $2.055.124.098 | 4.944.600 | 0,56% | Verkaufsoption |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $2.013.971.605 | 7.442.890 | 0,54% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $1.946.353.016 | 4.682.496 | 0,53% | Aktien |
| AMERIPRISE FINANCIAL INC | $1.875.407.666 | 4.510.354 | 0,51% | Aktien |
| HSBC HOLDINGS PLC | $1.662.111.390 | 3.992.237 | 0,45% | Aktien |
| Nuveen, LLC | $1.555.270.921 | 3.741.960 | 0,42% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $1.526.781.892 | 3.673.416 | 0,41% | Aktien |
| WELLS FARGO & COMPANY/MN | $1.503.990.279 | 3.618.579 | 0,41% | Aktien |
| UBS Group AG | $1.479.893.008 | 3.560.602 | 0,40% | Aktien |
| BARCLAYS PLC | $1.424.488.286 | 3.427.299 | 0,38% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $1.374.213.210 | 3.306.337 | 0,37% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1.251.138.985 | 3.010.223 | 0,34% | Aktien |
| Grantham, Mayo, Van Otterloo & Co. LLC | $1.174.164.878 | 2.825.022 | 0,32% | Aktien |
| UBS Group AG | $1.092.471.817 | 2.628.472 | 0,30% | Kaufoption |
| Mitsubishi UFJ Asset Management Co., Ltd. | $1.065.664.884 | 2.563.973 | 0,29% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| UnitedHealth Group Incorporated ×3 Einreichungen | 15. Januar 2021 | · | Erste Einreichung | M&A / Verkauf | SEC |
| Ingenix, Inc., UnitedHealth Group Incorporated | 5. Juni 2006 | · | Erste Einreichung | M&A / Verkauf | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 64 Insider · 39 Führungskräfte · 27 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Patrick Hugh Conway | Chief Executive Officer, Optum | 22. September 2026 A | 15.419 | 0 | 3 | $-944.910 |
| Timothy John Noel | Chief Executive Officer, UHC | 22. September 2026 A | 17.735 | 0 | 0 | $0 |
| Stephen J Hemsley | CEO, UHG | 22. September 2026 A | 177.690 | 0 | 0 | $0 |
| Heather Cianfrocco | Chief Executive Officer, Optum | 18. März 2025 A | 22.438 | 0 | 0 | $0 |
| Andrew Witty | CEO, UHG | 18. März 2025 A | 112.162 | 0 | 0 | $0 |
| Brian R Thompson | CEO, UnitedHealthcare | 24. September 2024 A | 32.675 | 0 | 0 | $0 |
| David S Wichmann | Chief Executive Officer | 16. Dezember 2020 F | 967.872 | 0 | 0 | $0 |
| Steven H Nelson | EVP & CEO, UnitedHealthcare | 25. Juni 2019 A | 38.502 | 0 | 0 | $0 |
| Larry C Renfro | Vice Chmn, UHG and CEO, Optum | 26. Juni 2018 A | 153.790 | 0 | 0 | $0 |
| Gail Boudreaux | EVP & CEO, UnitedHealthcare | 23. September 2014 A | 184.732 | 0 | 0 | $0 |
| George Lawrence Mikan III | EVP UHG & CEO, Optum | 5. Juni 2011 F | 209.279 | 0 | 0 | $0 |
| Tracy L Bahl | CEO, Uniprise | 7. November 2006 A | 4.230 | 0 | 0 | $0 |
| Robert J Sheehy | CEO, UnitedHealthcare | 7. November 2006 A | 3.009 | 0 | 0 | $0 |
| MCGUIRE WILLIAM W | Chief Executive Officer | 7. November 2006 A | 644.862 | 0 | 0 | $0 |
| Channing R Wheeler | CEO, Uniprise, Inc. | 28. November 2003 J | 8.356 | 0 | 0 | $0 |
| Wayne S Deveydt | Chief Financial Officer | 22. September 2026 A | 18.676 | 0 | 0 | $0 |
| John F Rex | President & CFO | 24. Juni 2025 A | 203.898 | 0 | 0 | $0 |
| Patrick J Erlandson | Chief Financial Officer | 2. Mai 2006 A | 7.083 | 0 | 0 | $0 |
| Dirk C Mcmahon | President & COO, UHG | 19. März 2024 A | 70.547 | 0 | 0 | $0 |
| Dennis Andrew Stankiewicz | Chief Accounting Officer | 22. September 2026 A | 10.109 | 0 | 0 | $0 |
| Christopher R Zaetta | EVP & Chief Legal Officer | 22. September 2026 A | 15.927 | 0 | 0 | $0 |
| Erin Mcsweeney | EVP & Chief People Officer | 22. September 2026 A | 15.654 | 0 | 0 | $0 |
| Thomas E Roos | Chief Accounting Officer | 23. Februar 2026 A | 31.284 | 0 | 0 | $0 |
| Rupert M Bondy | EVP & Chief Legal Officer | 19. März 2024 A | 9.607 | 0 | 0 | $0 |
| Marianne D Short | EVP & Chief Legal Officer | 25. Februar 2022 F | 138.315 | 0 | 0 | $0 |
| Patricia L Lewis | EVP and Chief HR Officer | 13. Februar 2022 F | 8.901 | 0 | 0 | $0 |
| Ellen D Wilson | Executive Vice President | 24. März 2020 A | 58.387 | 0 | 0 | $0 |
| Eric S Rangen | Sr VP & Chief Acctg Officer | 24. Juni 2015 A | 11.577 | 0 | 0 | $0 |
| Lori Sweere | EVP, Human Capital | 10. Mai 2013 S | 70.661 | 0 | 0 | $0 |
| Richard N Baer | EVP & Chief Legal Officer | 28. Dezember 2012 F | 63.880 | 0 | 0 | $0 |
| Reed Vaughn Tuckson | EVP & Chief of Medical Affairs | 5. Juni 2012 F | 116.886 | 0 | 0 | $0 |
| William A Munsell | EVP, UnitedHealth Group | 5. Juni 2012 F | 268.167 | 0 | 0 | $0 |
| Anthony Welters | EVP, UnitedHealth Group | 5. Juni 2012 F | 119.909 | 0 | 0 | $0 |
| Christopher James Walsh | EVP and General Counsel | 24. Mai 2011 A | 101.338 | 0 | 0 | $0 |
| Mitchell Eliot Zamoff | EVP and General Counsel | 24. Mai 2011 A | 113.613 | 0 | 0 | $0 |
| Thomas L Strickland | EVP & Chief Legal Officer | 5. Juni 2008 A | 147.182 | 0 | 0 | $0 |
| Richard H Anderson | EVP, Pres, Commercial Svcs Grp | 28. Mai 2007 A | 40.606 | 0 | 0 | $0 |
| Lois E Quam | EVP & Pres, Pub & Sr Mkt Grp | 28. Mai 2007 A | 13.915 | 0 | 0 | $0 |
| Forrest Gregory Burke | Acting General Counsel | 17. April 2007 A | · | 0 | 0 | $0 |
| Frederick William Mcnabb III | Direktor | 22. September 2026 A | 15.519 | 0 | 0 | $0 |
| Kristen Gil | Direktor | 22. September 2026 A | 2.627 | 0 | 0 | $0 |
| Rice Valerie Montgomery MD | Direktor | 22. September 2026 A | 7.923 | 0 | 0 | $0 |
| John H Noseworthy | Direktor | 22. September 2026 A | 7.662 | 0 | 0 | $0 |
| Charles D. Baker | Direktor | 22. September 2026 A | 2.411 | 0 | 0 | $0 |
| Timothy Patrick Flynn | Direktor | 22. September 2026 A | 10.943 | 0 | 0 | $0 |
| Scott Gottlieb | Direktor | 22. September 2026 A | 664 | 0 | 0 | $0 |
| Paul R Garcia | Direktor | 22. September 2026 A | 3.922 | 0 | 0 | $0 |
| Michele J Hooper | Direktor | 1. April 2026 A | 41.792 | 0 | 0 | $0 |
| BURKE RICHARD T | Direktor | 19. Mai 2022 S | 1.215.000 | 0 | 0 | $0 |
| Gail R Wilensky | Direktor | 1. April 2022 A | 24.690 | 0 | 0 | $0 |
| Glenn M Renwick | Direktor | 1. April 2021 A | 85.130 | 0 | 0 | $0 |
| BALLARD WILLIAM C JR | Direktor | 1. April 2020 A | 62.266 | 0 | 0 | $0 |
| Kenneth Irwin Shine | Direktor | 13. Dezember 2018 A | 29.250 | 0 | 0 | $0 |
| Rodger A Lawson | Direktor | 2. April 2018 A | 28.035 | 0 | 0 | $0 |
| Robert J Darretta | Direktor | 3. April 2017 A | 54.480 | 0 | 0 | $0 |
| Edson De Godoy Bueno | Direktor | 8. Februar 2017 A | 188.305 | 0 | 0 | $0 |
| LEATHERDALE DOUGLAS W | Direktor | 1. April 2015 A | 921.644 | 0 | 0 | $0 |
| Mary Oneil Mundinger | Direktor | 5. Juni 2008 A | 32.000 | 0 | 0 | $0 |
| Thomas H Kean | Direktor | 5. Juni 2008 A | 44.000 | 0 | 0 | $0 |
| JOHNSON JAMES A /DC/ | Direktor | 5. Juni 2008 A | 0 | 0 | 0 | $0 |
| RYAN ROBERT L | Direktor | 5. Juni 2008 A | 16.000 | 0 | 0 | $0 |
| Donna E Shalala | Direktor | 2. April 2007 A | 0 | 0 | 0 | $0 |
| SPEARS WILLIAM G | Direktor | 2. Oktober 2006 A | 64.896 | 0 | 0 | $0 |
| LUBBEN DAVID J | · | 31. Oktober 2005 A | 1.761 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 176 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IHF · iShares Trust | 20,07% | 677.912 SH | 11. September 2026 | Täglich |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 5,85% | 1.281 NS | 31. Juli 2026 | N-PORT |
| IYH · iShares Trust | 5,65% | 528.565 SH | 11. September 2026 | Täglich |
| DOGG · First Trust Exchange-Traded Fund IV | 5,59% | 11.977 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 5,56% | 2.728.542 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 5,44% | 431.779 NS | 31. Juli 2026 | N-PORT |
| JXX · Janus Detroit Street Trust | 5,04% | 3.245 NS | 31. Juli 2026 | N-PORT |
| DJIA · Global X Funds | 4,75% | 21.103 NS | 31. Juli 2026 | N-PORT |
| DYLG · Global X Funds | 4,72% | 704 NS | 31. Juli 2026 | N-PORT |
| DJD · Invesco Exchange-Traded Fund Trust | 4,72% | 63.097 SH | 1. Oktober 2026 | Täglich |
| FLAG · Global X Funds | 4,39% | 180 NS | 31. Juli 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 4,31% | 17.869 NS | 31. Juli 2026 | N-PORT |
| IXJ · iShares Trust | 4,01% | 428.796 SH | 11. September 2026 | Täglich |
| EQIN · Columbia ETF Trust I | 3,97% | 29.103 NS | 31. Juli 2026 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 3,30% | 163.100 SH | 1. Oktober 2026 | Täglich |
| BKDV · BNY Mellon ETF Trust II | 2,96% | 131.299 NS | 31. Juli 2026 | N-PORT |
| VEGN · ETF Series Solutions | 2,73% | 11.696 NS | 31. Juli 2026 | N-PORT |
| TBG · EA Series Trust | 2,67% | 16.761 NS | 31. Juli 2026 | N-PORT |
| CBLS · Elevation Series Trust | 2,64% | 3.546 NS | 31. Juli 2026 | N-PORT |
| DUSA · Davis Fundamental ETF Trust | 2,17% | 66.700 NS | 31. Juli 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 2,17% | 570.930 SH | 1. Oktober 2026 | Täglich |
| MTUM · iShares Trust | 2,08% | 1.301.923 SH | 11. September 2026 | Täglich |
| FDIV · EA Series Trust | 2,01% | 2.839 NS | 31. Juli 2026 | N-PORT |
| HGRO · ETF Opportunities Trust | 1,92% | 5.834 NS | 31. Juli 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 1,78% | 570.801 SH | 19. August 2026 | Täglich |
| JGLO · J.P. Morgan Exchange-Traded Fund Tr… | 1,70% | 273.276 NS | 31. Juli 2026 | N-PORT |
| SRHQ · Elevation Series Trust | 1,69% | 8.633 NS | 31. Juli 2026 | N-PORT |
| DGRO · iShares Trust | 1,66% | 1.832.156 SH | 11. September 2026 | Täglich |
| VIG · VANGUARD SPECIALIZED FUNDS | 1,65% | 5.130.541 SH | 19. August 2026 | Täglich |
| VYM · VANGUARD WHITEHALL FUNDS | 1,56% | 3.604.520 SH | 19. August 2026 | Täglich |
| SPMO · Invesco Exchange-Traded Fund Trust … | 1,54% | 966.955 SH | 1. Oktober 2026 | Täglich |
| DFLV · Dimensional ETF Trust | 1,54% | 250.908 NS | 31. Juli 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,52% | 36.275 SH | 1. Oktober 2026 | Täglich |
| FDRR · FIDELITY COVINGTON TRUST | 1,51% | 26.902 NS | 31. Juli 2026 | N-PORT |
| QUVU · Hartford Funds Exchange-Traded Trust | 1,47% | 6.400 NS | 31. Juli 2026 | N-PORT |
| FBCV · FIDELITY COVINGTON TRUST | 1,45% | 6.215 NS | 31. Juli 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 1,42% | 527.846 NS | 31. Juli 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 1,41% | 8.635.243 SH | 19. August 2026 | Täglich |
| MEDI · Harbor ETF Trust | 1,39% | 1.382 NS | 31. Juli 2026 | N-PORT |
| BIGY · Tidal Trust II | 1,39% | 1.821 NS | 31. Juli 2026 | N-PORT |
| JDIV · J.P. Morgan Exchange-Traded Fund Tr… | 1,38% | 428 NS | 31. Juli 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 1,32% | 1.367 NS | 31. Juli 2026 | N-PORT |
| DWLD · Davis Fundamental ETF Trust | 1,31% | 19.334 NS | 31. Juli 2026 | N-PORT |
| FFLC · FIDELITY COVINGTON TRUST | 1,31% | 38.014 NS | 31. Juli 2026 | N-PORT |
| IWX · iShares Trust | 1,30% | 130.382 SH | 11. September 2026 | Täglich |
| VOOV · VANGUARD ADMIRAL FUNDS | 1,30% | 209.110 SH | 19. August 2026 | Täglich |
| VMAX · Lattice Strategies Trust | 1,27% | 1.502 NS | 31. Juli 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 1,26% | 33.024 SH | 1. Oktober 2026 | Täglich |
| PFM · Invesco Exchange-Traded Fund Trust | 1,22% | 25.570 SH | 1. Oktober 2026 | Täglich |
| DIVB · iShares Trust | 1,21% | 63.584 SH | 11. September 2026 | Täglich |
| FDLO · FIDELITY COVINGTON TRUST | 1,20% | 41.317 NS | 31. Juli 2026 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 1,19% | 38.160 NS | 31. Juli 2026 | N-PORT |
| IVE · iShares Trust | 1,18% | 1.508.315 SH | 11. September 2026 | Täglich |
| DIVD · EA Series Trust | 1,16% | 597 NS | 31. Juli 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 1,13% | 301.925 SH | 1. Oktober 2026 | Täglich |
| OEI · Listed Funds Trust | 1,12% | 1.253 NS | 31. Juli 2026 | N-PORT |
| IUSV · iShares Trust | 1,12% | 794.630 SH | 11. September 2026 | Täglich |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 1,06% | 2.884 NS | 31. Juli 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 1,05% | 545.124 SH | 19. August 2026 | Täglich |
| LGDX · Tidal Trust III | 1,04% | 3.557 NS | 31. Juli 2026 | N-PORT |
| FBUF · Fidelity Greenwood Street Trust | 1,03% | 595 NS | 31. Juli 2026 | N-PORT |
| FHEQ · Fidelity Greenwood Street Trust | 1,03% | 23.120 NS | 31. Juli 2026 | N-PORT |
| FYEE · Fidelity Greenwood Street Trust | 1,03% | 5.430 NS | 31. Juli 2026 | N-PORT |
| ILCV · iShares Trust | 1,02% | 35.291 SH | 11. September 2026 | Täglich |
| FFLV · FIDELITY COVINGTON TRUST | 1,00% | 396 NS | 31. Juli 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,98% | 27.976.000 | 1. Oktober 2026 | Täglich |
| JOYT · J.P. Morgan Exchange-Traded Fund Tr… | 0,98% | 2.306 NS | 31. Juli 2026 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 0,95% | 71.659 SH | 1. Oktober 2026 | Täglich |
| IWD · iShares Trust | 0,94% | 2.006.595 SH | 11. September 2026 | Täglich |
| MPLY · Strategy Shares | 0,92% | 353 NS | 31. Juli 2026 | N-PORT |
| EVUS · iShares Trust | 0,91% | 8.940 SH | 11. September 2026 | Täglich |
| GLBL · Pacer Funds Trust | 0,90% | 24 NS | 31. Juli 2026 | N-PORT |
| EGLE · Global X Funds | 0,87% | 46 NS | 31. Juli 2026 | N-PORT |
| ACIO · ETF Series Solutions | 0,83% | 46.892 NS | 31. Juli 2026 | N-PORT |
| ADME · ETF Series Solutions | 0,82% | 5.790 NS | 31. Juli 2026 | N-PORT |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,78% | 35.741.000 | 1. Oktober 2026 | Täglich |
| XLG · Invesco Exchange-Traded Fund Trust | 0,78% | 248.181 SH | 1. Oktober 2026 | Täglich |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0,77% | 12.065 NS | 31. Juli 2026 | N-PORT |
| OEF · iShares Trust | 0,74% | 383.938 SH | 11. September 2026 | Täglich |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0,72% | 80.708 NS | 31. Juli 2026 | N-PORT |
| MGC · VANGUARD WORLD FUND | 0,71% | 181.588 SH | 19. August 2026 | Täglich |
| FBCG · FIDELITY COVINGTON TRUST | 0,68% | 113.499 NS | 31. Juli 2026 | N-PORT |
| INFO · Harbor ETF Trust | 0,68% | 13.747 NS | 31. Juli 2026 | N-PORT |
| USCL · iShares Trust | 0,66% | 48.067 SH | 11. September 2026 | Täglich |
| TOPC · iShares Trust | 0,65% | 552 SH | 11. September 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,64% | 35.145 NS | 31. Juli 2026 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0,64% | 204.138 SH | 19. August 2026 | Täglich |
| RPV · Invesco Exchange-Traded Fund Trust | 0,62% | 27.777 SH | 1. Oktober 2026 | Täglich |
| IWL · iShares Trust | 0,62% | 35.096 SH | 11. September 2026 | Täglich |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,62% | 838.000 | 1. Oktober 2026 | Täglich |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,61% | 21.461.000 | 1. Oktober 2026 | Täglich |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,61% | 12.196 NS | 31. Juli 2026 | N-PORT |
| XVV · iShares Trust | 0,60% | 10.452 SH | 11. September 2026 | Täglich |
| VV · VANGUARD INDEX FUNDS | 0,60% | 1.060.618 SH | 19. August 2026 | Täglich |
| XYLD · Global X Funds | 0,59% | 46.222 NS | 31. Juli 2026 | N-PORT |
| XRMI · Global X Funds | 0,59% | 711 NS | 31. Juli 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,59% | 23.589.295 SH | 19. August 2026 | Täglich |
| XYLG · Global X Funds | 0,59% | 909 NS | 31. Juli 2026 | N-PORT |
| XTR · Global X Funds | 0,59% | 68 NS | 31. Juli 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,58% | 45.982 NS | 31. Juli 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,58% | 125.037 NS | 31. Juli 2026 | N-PORT |
| XCLR · Global X Funds | 0,58% | 50 NS | 31. Juli 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,58% | 76.661 NS | 31. Juli 2026 | N-PORT |
| TOV · EA Series Trust | 0,58% | 3.693 NS | 31. Juli 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,58% | 15.333 NS | 31. Juli 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,57% | 25.912 SH | 1. Oktober 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,55% | 275.366 NS | 31. Juli 2026 | N-PORT |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,54% | 149.315 SH | 19. August 2026 | Täglich |
| PALC · Pacer Funds Trust | 0,54% | 2.737 NS | 31. Juli 2026 | N-PORT |
| IVV · iShares Trust | 0,54% | 11.446.549 SH | 11. September 2026 | Täglich |
| SPUU · Direxion Shares ETF Trust | 0,54% | 3.427 NS | 31. Juli 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,53% | 21.871 NS | 31. Juli 2026 | N-PORT |
| ILCB · iShares Trust | 0,53% | 17.613 SH | 11. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,52% | 28.835.934 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,52% | 76.032 SH | 19. August 2026 | Täglich |
| PBP · Invesco Exchange-Traded Fund Trust | 0,51% | 5.340 SH | 1. Oktober 2026 | Täglich |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,51% | 156.747 SH | 1. Oktober 2026 | Täglich |
| IYY · iShares Trust | 0,50% | 38.951 SH | 11. September 2026 | Täglich |
| IWB · iShares Trust | 0,50% | 625.110 SH | 11. September 2026 | Täglich |
| ROUS · Lattice Strategies Trust | 0,50% | 8.454 NS | 31. Juli 2026 | N-PORT |
| FDVV · FIDELITY COVINGTON TRUST | 0,50% | 121.474 NS | 31. Juli 2026 | N-PORT |
| PEVC · Pacer Funds Trust | 0,48% | 28 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,48% | 249.175 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,48% | 1.182.316 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,48% | 25.122 NS | 31. Juli 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,48% | 14.239.000 | 30. September 2026 | Täglich |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,47% | 60.563 SH | 1. Oktober 2026 | Täglich |
| HCMT · Direxion Shares ETF Trust | 0,47% | 6.322 NS | 31. Juli 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,46% | 9.451 SH | 19. August 2026 | Täglich |
| ESGU · iShares Trust | 0,44% | 202.733 SH | 11. September 2026 | Täglich |
| SPXL · Direxion Shares ETF Trust | 0,44% | 70.995 NS | 31. Juli 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0,44% | 467.199 SH | 11. September 2026 | Täglich |
| PHDG · Invesco Actively Managed Exchange-T… | 0,42% | 707 SH | 1. Oktober 2026 | Täglich |
| TOK · iShares Trust | 0,41% | 2.510 SH | 11. September 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,41% | 122.340 NS | 31. Juli 2026 | N-PORT |
| HDUS · Lattice Strategies Trust | 0,40% | 1.981 NS | 31. Juli 2026 | N-PORT |
| USMV · iShares Trust | 0,40% | 242.282 SH | 11. September 2026 | Täglich |
| URTH · iShares, Inc. | 0,39% | 81.588 SH | 11. September 2026 | Täglich |
| DFVX · Dimensional ETF Trust | 0,39% | 4.920 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,37% | 29.776 NS | 31. Juli 2026 | N-PORT |
| ACWI · iShares Trust | 0,34% | 289.261 SH | 11. September 2026 | Täglich |
| CRBN · iShares Trust | 0,34% | 10.086 SH | 11. September 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,32% | 755.775 SH | 19. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,30% | 351.178 NS | 31. Juli 2026 | N-PORT |
| LRGF · iShares Trust | 0,28% | 26.776 SH | 11. September 2026 | Täglich |
| VFMF · VANGUARD WELLINGTON FUND | 0,27% | 4.562 SH | 19. August 2026 | Täglich |
| ESMV · iShares Trust | 0,27% | 53 SH | 11. September 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,24% | 3.193 NS | 31. Juli 2026 | N-PORT |
| FFLG · FIDELITY COVINGTON TRUST | 0,24% | 3.356 NS | 31. Juli 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,20% | 10.042 SH | 11. September 2026 | Täglich |
| HEQQ · J.P. Morgan Exchange-Traded Fund Tr… | 0,19% | 140 NS | 31. Juli 2026 | N-PORT |
| VOXP · Advisors Series Trust | 0,19% | 27 NS | 31. Juli 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,19% | 497.644 SH | 1. Oktober 2026 | Täglich |
| SIZE · iShares Trust | 0,17% | 1.897 SH | 11. September 2026 | Täglich |
| GLOF · iShares Trust | 0,15% | 779 SH | 11. September 2026 | Täglich |
| JFLI · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 171 NS | 31. Juli 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 1.635 NS | 31. Juli 2026 | N-PORT |
| ACWV · iShares, Inc. | 0,15% | 12.606 SH | 11. September 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 1.943 SH | 1. Oktober 2026 | Täglich |
| QDEF · FlexShares Trust | 0,02% | 246 NS | 31. Juli 2026 | N-PORT |
| QDF · FlexShares Trust | 0,02% | 977 NS | 31. Juli 2026 | N-PORT |
| GTO · Invesco Actively Managed Exchange-T… | 0,00% | 7.000 | 30. September 2026 | Täglich |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VSDB · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30. Juli 2026 | Täglich |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30. Juli 2026 | Täglich |
| VCEB · VANGUARD WORLD FUND | · | · | 30. Juli 2026 | Täglich |
UNH Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 34 Analysten
KAUF
Median-Ziel
$490.00
+31,8%
8 23,5%
Starker Kauf
19 55,9%
Kauf
7 20,6%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
25 Analysten · 2026-10-03Mittelwert-Ziel $481.72 +29,5%
← Unter allen Zielen
Aktueller Preis $371.90
Tief$380.00
Mittelwert$481.72
Hoch$529.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Ist die Aktie von UnitedHealth noch unterbewertet?
Nasdaq · 1 Monat, 3 Wochen vor
UnitedHealth Lost Nearly 1 Million Medicare Members. Here's Why Investors Aren't Worried
Yahoo Finance · 2 Monate, 2 Wochen vor
UnitedHealth Group boosts earnings outlook after stronger-than-expected Q2 results
Yahoo Finance · 2 Monate, 2 Wochen vor
UnitedHealth Group: Ein Kauf nach dem jüngsten Gewinnbericht?
Yahoo Finance · 2 Monate, 2 Wochen vor
JPMorgan Raises its Price Target on UnitedHealth Group (UNH)
Yahoo Finance · 3 Monate, 2 Wochen vor
UnitedHealth Stock Jumps on Upgrade From Bank of America. UNH Is No Longer Just an Insurance Company.
Yahoo Finance · 3 Monate, 3 Wochen vor
Täglicher Dividendenbericht: MDT, ACM, UNH, RICK, VRT
Nasdaq · 3 Monate, 4 Wochen vor
Dieser Gesundheitsriese wird leise zu einem KI-Kraftwerk
Nasdaq · 4 Monate, 1 Woche vor
UnitedHealth Group (UNH) – Unter den 10 Qualitätsaktien, die laut Hedgefonds gekauft werden sollten
Yahoo Finance · 4 Monate, 1 Woche vor
UnitedHealth (UNH) Aktien fallen nach Ausstieg von Berkshire Hathaway, berichtet Reuters
Yahoo Finance · 4 Monate, 1 Woche vor
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
BLUECHIP_DIP
Stop-Loss ausgelöst
Risiko 1
Belohnung 2,08
Einstieg
$381.02
R:R 2,08
BLUECHIP_DIP
Stop-Loss ausgelöst
Risiko 1
Belohnung 2,08
Einstieg
$406.25
R:R 2,08
Derzeit kein offenes Signal – keine Karte ist ausgefüllt, und das ist ehrlich.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 10, 2026